Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) – Investment analysts at SunTrust Banks increased their Q3 2017 earnings per share (EPS) estimates for shares of Sabra Healthcare REIT in a report issued on Thursday. SunTrust Banks analyst E. Fleming now expects that the real estate investment trust will post earnings per share of $0.59 for the quarter, up from their previous forecast of $0.56. SunTrust Banks also issued estimates for Sabra Healthcare REIT’s Q4 2017 earnings at $0.60 EPS, Q2 2018 earnings at $0.64 EPS, Q3 2018 earnings at $0.60 EPS, Q4 2018 earnings at $0.62 EPS, FY2018 earnings at $2.46 EPS and FY2019 earnings at $2.69 EPS.
Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, May 8th. The real estate investment trust reported $0.25 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.33. The company had revenue of $62.65 million for the quarter, compared to analysts’ expectations of $63.47 million. Sabra Healthcare REIT had a net margin of 34.99% and a return on equity of 8.72%. Sabra Healthcare REIT’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter last year, the firm posted $0.54 earnings per share.
ILLEGAL ACTIVITY WARNING: “Q3 2017 EPS Estimates for Sabra Healthcare REIT, Inc. Increased by Analyst (NASDAQ:SBRA)” was originally posted by Rincon Hill News and is owned by of Rincon Hill News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://rinconhillneighbors.org/2017/08/19/q3-2017-eps-estimates-for-sabra-healthcare-reit-inc-increased-by-analyst-nasdaqsbra-updated.html.
Several other equities research analysts also recently weighed in on the company. Zacks Investment Research raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Stifel Nicolaus reaffirmed a “hold” rating and set a $26.00 price target on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. BidaskClub raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. Mizuho downgraded Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $25.00 to $23.00 in a research report on Monday, July 10th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $25.00 price target (down from $28.00) on shares of Sabra Healthcare REIT in a research report on Sunday, July 9th. One analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $26.57.
Sabra Healthcare REIT (NASDAQ:SBRA) opened at 22.99 on Monday. The company’s 50-day moving average price is $23.62 and its 200 day moving average price is $25.42. The stock has a market capitalization of $1.50 billion, a P/E ratio of 19.35 and a beta of 0.89. Sabra Healthcare REIT has a 52-week low of $19.30 and a 52-week high of $29.10.
Large investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Sabra Healthcare REIT by 9.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,151 shares of the real estate investment trust’s stock valued at $100,000 after buying an additional 352 shares during the last quarter. Bank of Montreal Can raised its stake in Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock valued at $109,000 after buying an additional 1,191 shares during the last quarter. Russell Investments Group Ltd. purchased a new stake in Sabra Healthcare REIT during the fourth quarter valued at about $120,000. Daiwa Securities Group Inc. raised its stake in Sabra Healthcare REIT by 15.7% in the second quarter. Daiwa Securities Group Inc. now owns 5,900 shares of the real estate investment trust’s stock valued at $142,000 after buying an additional 800 shares during the last quarter. Finally, Ameritas Investment Partners Inc. purchased a new stake in Sabra Healthcare REIT during the first quarter valued at about $156,000. 99.26% of the stock is currently owned by institutional investors and hedge funds.
The company also recently announced a dividend, which will be paid on Friday, August 18th. Stockholders of record on Wednesday, August 16th will be paid a dividend of $0.3599 per share. The ex-dividend date is Monday, August 14th. Sabra Healthcare REIT’s payout ratio is currently 145.76%.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with our FREE daily email newsletter.